39128 Federal Register / Vol. 83, No. 153 / Wednesday, August 8, 2018 / Notices 

sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/LJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DRW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on June 

29, 2018, Clinical Supplies Management 

Holdings, Inc., 342 42nd Street South, 

Fargo, North Dakota 58103–1132 

applied to be registered as an importer 

of the following basic classes of 

controlled substances: 

Controlled substance Drug 

code Schedule 

Marihuana ..................... 7360 I 

Tetrahydrocannabinols 7370 I 

The company plans to import the 

listed controlled substances to 

manufacture bulk controlled substances 

for use in clinical trials only. 

Dated: July 31, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–16939 Filed 8–7–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: AndersonBrecon Inc. 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before September 7, 2018. Such 

persons may also file a written request 

for a hearing on the application on or 

before September 7, 2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for hearing must be 

sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/LJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DRW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

Comments and requests for hearings on 

applications to import narcotic raw 

material are not appropriate. 72 FR 

3417, (January 25, 2007) 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on May 2, 

2018, AndersonBrecon Inc., 5775 

Logistics Parkway, Rockford, Illinois 

61109 applied to be registered as an 

importer of the following basic class of 

controlled substance: 

Controlled substance Drug 

code Schedule 

Tetrahydrocannabinols ......................................................................................................................................... 7370 I 

The company plans to import the 

listed controlled substances for clinical 

trial only. Approval of permit 

applications will occur only when the 

registrant’s business activity is 

consistent with what is authorized 

under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of FDA approved or nonapproved finished dosage forms for 

commercial sale. 

Dated: July 31, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–16937 Filed 8–7–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Registration 

ACTION: Notice of registration. 

SUMMARY: Registrants listed below have 

applied for and been granted 

registration by-the Drug Enforcement 

Administration (DEA) as importers of 

various classes of schedule I or II 

controlled substances. 

SUPPLEMENTARY INFORMATION: The 

companies listed below applied to be 

registered as importers of various basic 

classes of controlled substances. 

Information on previously published 

notices is listed in the table below. No 

comments or objections were submitted 

and no requests for hearing were 

submitted for these notices. 


sradovich on DSK3GMQ082PROD with NOTICES